Archive

Human HIV Vaccine Trial Begins With BRILLIANT 011

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

Read More

Bonitas Tender Dispute: Court Action and Tender Controversy

Get insights into the Bonitas Tender Dispute as Bonitas reacts to Medscheme’s challenge over service provider appointments.

Read More

Bonitas Medscheme Split Sees Momentum and PHA Win Contracts

Bonitas Medscheme split sees Momentum Health and PHA take over key contracts, as a CMS forensic probe and court action continue.

Read More

African Genome Diversity: Wits-Led AGenDA Adds 1,000 Genomes

The African Genome Diversity effort led by Wits adds 1,000+ genomes, improving AI models and precision medicine for African populations.

Read More

Mental Health VAT Reform: Cost Trap Deepens Care Gap

South Africans are reporting rising levels of depression and anxiety. Yet access to care is tightening. High out-of-pocket costs and an entrenched shortage of mental health professionals are leaving many people underserved. In particular, those with the greatest need are most affected.

Read More

Road Accident Fund Insolvency has Deep Roots, Scopa Told

Understand the longstanding insolvency of the Road Accident Fund and the factors contributing to its financial distress.

Read More

Wits Health Research Funding Boost Targets Immediate Gaps

Wits Health Research Funding receives a R7m boost from the Oppenheimer Memorial Trust to support those affected by US funding cuts.

Read More

Botswana Medicine Shortages Expose Deep Procurement Failures

Botswana Medicine Shortages are worsening as procurement delays, weak supply chains, and poor data systems leave clinics without drugs.

Read More

Roche CT-388 Obesity Drug Posts 22.5% Weight Loss

Roche CT-388 Obesity Drug shows up to 22.5% placebo-adjusted weight loss at 48 weeks, as Roche moves into Phase 3 to challenge Lilly and Novo.

Read More

AI in Drug Development helps Pharma Cut Trial Admin Time

AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.

Read More

HIV ARV Tender Crisis Triggers Parliamentary Scrutiny

South Africa faces an HIV ARV tender crisis as major suppliers enter business rescue, risking vital medicine availability.

Read More

WhatsApp Microlearning: Solving a Persistent HIV Training Gap

WhatsApp Microlearning helps clinics deliver quick, practical HIV policy updates, improving guideline uptake and service delivery.

Read More